none19siPancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at a late stage. Little is known about the incidental finding of early-stage PDAC. The aim of the current study was to determine the etiology of small solid pancreatic lesions (≤15 mm) to optimize clinical management.mixedDietrich, Christoph Frank; Sahai, Anand Vasante; D'Onofrio, Mirko; Will, Uwe; Arcidiacono, Paolo Giorgio; Petrone, Maria Chiara; Hocke, Michael; Braden, Barbara; Burmester, Eike; Möller, Kathleen; Săftoiu, Adrian; Ignee, Andre; Cui, Xin-Wu; Iordache, Sevastita; Potthoff, Andrej; Iglesias-Garcia, Julio; Fusaroli, Pietro; Dong, Yi; Jenssen, ChristianDietrich, Christoph Frank; Sahai, Anand Vasante; D'Onofrio, Mirko; Will, Uwe; Arcidiacono, Paolo Giorg...
PubMed: 22711682Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC...
Pancreatic ductal adenocarcinoma (PDAC) represents permanent and ever rising issue worldwide. Five-y...
Background: The prevalence of pancreatic ductal adenocarcinoma (PDAC) is on the rise, driven by fact...
Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at a late stage. Little is known abou...
Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent malignant pancreatic tumor. Few studie...
Abstract: Pancreatic cancer (PC) is estimated to become the second lead-ing cause of cancer death in...
Pancreatic ductal adenocarcinoma (PDAC) and its variants comprise between 80% and 90% of all tumors ...
Most pancreatic ductal adenocarcinoma cases are unresectable at the time of diagnosis. Only early di...
none16noPancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of ca...
As the most common and most important cancer of the pancreas, with rapid mortality and now also as t...
To observe clinical and pathological features of pancreatic solid-pseudopapillary tumor (SPPT), and ...
Pancreatic ductal adenocarcinoma (PDAC) is supposed to become the second leading cancer-associated d...
Pancreatic ductal adenocarcinoma (PDAC) accounts for the majority of all pancreatic cancers and is h...
The study aimed to develop a prediction model for differentiating suspected PDAC from benign conditi...
Ductal adenocarcinoma is the most common pancreatic neoplasm. A variety of pancreatic lesions mimic ...
PubMed: 22711682Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC...
Pancreatic ductal adenocarcinoma (PDAC) represents permanent and ever rising issue worldwide. Five-y...
Background: The prevalence of pancreatic ductal adenocarcinoma (PDAC) is on the rise, driven by fact...
Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at a late stage. Little is known abou...
Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent malignant pancreatic tumor. Few studie...
Abstract: Pancreatic cancer (PC) is estimated to become the second lead-ing cause of cancer death in...
Pancreatic ductal adenocarcinoma (PDAC) and its variants comprise between 80% and 90% of all tumors ...
Most pancreatic ductal adenocarcinoma cases are unresectable at the time of diagnosis. Only early di...
none16noPancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of ca...
As the most common and most important cancer of the pancreas, with rapid mortality and now also as t...
To observe clinical and pathological features of pancreatic solid-pseudopapillary tumor (SPPT), and ...
Pancreatic ductal adenocarcinoma (PDAC) is supposed to become the second leading cancer-associated d...
Pancreatic ductal adenocarcinoma (PDAC) accounts for the majority of all pancreatic cancers and is h...
The study aimed to develop a prediction model for differentiating suspected PDAC from benign conditi...
Ductal adenocarcinoma is the most common pancreatic neoplasm. A variety of pancreatic lesions mimic ...
PubMed: 22711682Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC...
Pancreatic ductal adenocarcinoma (PDAC) represents permanent and ever rising issue worldwide. Five-y...
Background: The prevalence of pancreatic ductal adenocarcinoma (PDAC) is on the rise, driven by fact...